type 2 diabetes
Conditions
Interventions
Regular education: group A:Routine treatment & outpatient follow-up. Tips for blood glucose control and educational videos will be pushed in the first 3 months. Participants in this group master diabe
APP intervention group:group B:A 24-week (6 months) smartphone-based lifestyle intervention will be conducted. The learning of the participants in group B will be supervised by the research group. The
Sponsors
Kunshan First People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients with T2DM meeting the 2019 WHO diabetes diagnosis and classification criteria; 2. the latest HbA1c test result of 7%=HbA1c=10% 3. Time from diagnosis =1 year; 4. Local permanent resident population; 5. Age=18 years: 6. With normal cognition and communication skills, able to understand and accept the guidance and evaluation of chronic disease management; 7. Capable of using a smartphone; 8. Willing to participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Type 1 diabetes: 2. Pregnancy or planned to be pregnant within six months; 3. Insulin pump users; 4. Frequent medication adjustment needed due to unstable condition in the first three months; 5. With severe diabetic complications or obvious organ dysfunction; 6. History of alcohol or drug abuse; 7. Unable to operate mobile APP due to the ability of reading and cognition; 8. Patients with mental disorders who can not take care of themselves; 9. Patients with tumors who have received radiotherapy or chemotherapy in the past six months; 10. Patients who have participated in other relevant intensive lifestyle intervention studies in the past six months; 11. Patients who are participating in other research or health management projects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intergroup difference of HbA1c% reduation; | — |
Secondary
| Measure | Time frame |
|---|---|
| The decrease in HbA1c from baseline in both groups;Intergroup difference of fasting blood glucose;Intergroup difference of blood glucose compliance rate;Differences in blood lipids from baseline and between groups;Differences in liver function from baseline and between groups;Differences in renal function from baseline and between groups;Differences in inflammatory indicators from baseline and between groups;Differences in C-DMSES scores from baseline and between groups;Differences in PAID-5 scores from baseline and between groups;Differences in EQ-5D scores from baseline and between groups;Differences in blood glucose variability from baseline and between groups;Differences in mean weekly blood glucose monitoring from baseline and between groups;Intergroup difference of frequency of outpatient visits;Differences in physical activity from baseline and between groups; | — |
Countries
China
Contacts
Public ContactZhong Shao
Kunshan First People's Hospital
Outcome results
None listed